IN BRIEF
»
HIGH GROWTH EMERGING TECH FIRMS TO SET UP IRISH HQS
Three IDA Ireland client com- panies involved in high growth emerging technologies are to es- tablishtheir internationalhead- quarters in Dublin. The US-based companies, En-
gineYard, Pinger and Commence, specialise in disruptive technolo- gies that are linked to the fast growing cloud computing indus- try. The announcements are seen as
a strong endorsement that Ireland provides a supportive environ- ment for dynamic technology companies to flourish, enhancing our international reputation for cutting edge innovative busi- nesses.
JRI AMERICA SOFTWARE DEVELOPMENT FACILITY SET FOR TRALEE
JRI America is to establish a software development operation in Tralee that may create up to 100 highly skilled positions over the next five years. The company is the specialist
IT subsidiary of Japanese finan- cial services company Sumitomo Mitsui Financial Group (SMFG). The new facility will support the group’s western hemisphere IT operations including US, UK and Dubai. “We believe that Ireland offers
our company a unique opportu- nity where there is not only strong government support for innovation and business but also a deep pool of talented people with strong technical skills from which to build our team,” said Michael O’Dea, president and chief operating officer, JRI America.
GOOGLE INVESTING €75M IN ENERGY-EFFICIENT DATA CENTRE
Google has announced its plans to build anenergy-efficient, air-cooled data cen- tre inDublinina€75minvestment. The data centre will be constructed on
an 11-acre site in west Dublin. Up to 200 people will be employed during the con- struction phase, which is expected to take 12–15months.Once operational, the centre will employ up to 30 people in a variety of full-time and contractor roles. “We're very happy to continue invest-
ing in Ireland and to build out our pres- ence here even further,” said JohnHerlihy, head ofGoogle Ireland. “The newdata centrewill be one of the
most energy-efficient inGoogle's global fleet.”
An Taoiseach EndaKenny TD and FrankD'Amelio, vice-president and CFOof Pfizer
PROMETRIC LOCATES TEST DEVELOPMENT BUSINESS IN DUNDALK
Prometric has announced amajor investment in its test development services business in Ireland. Supported by IDA Ireland, the in-
vestment will enhance the support services and underlying technologies the company uses to provide test de- velopment services to many of the world’s leading test publishing brands. Test development solutions, a newly
organised global function, will be headquartered in Dundalk, with em- ployees spread throughout Prometric’s global network of operational offices. The new headquarters is expected to grow to more than 100 employees by 2014. The new Irish operation will aug-
ment existing operations in the US, India and Japan and, when complete, will almost double the size of the Pro- metric workforce dedicated to job task analyses, test item development, exam publishing, test score analysis and re- porting and test publishing systems’ development.
PFIZER INVESTING €145M IN DUBLIN BIOTECH FACILITY
Biopharma company Pfizer is to inject€145minto its Dublin biotechmanufacturing facility inGrange Castle – one of the largest biotechmanufacturing sites in theworld – creating up to 400 jobs during the peak of the construction phase. The investment will enable
Pfizer to introduce two new pro- cessing suites to the site and ex- pand current production and product testing capabilities. Pfizer's Grange Castle facility in
Clondalkin, Co Dublin, currently produces two of the pharama giant's blockbuster medicines – Enbrel and Prevenar 13. “Pfizer has made a tremendous
contribution to Ireland's life sci- ences industry since it first estab- lished here in 1969 and this investment is a further demon- stration of the company's continu- ous commitment to Ireland,” said An Taoiseach Enda Kenny TD.
Issue 3 Autumn/Winter 2011 INNOVATION IRELAND REVIEW 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80